Correlation Between 23Andme Holding and Orchestra BioMed

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both 23Andme Holding and Orchestra BioMed at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining 23Andme Holding and Orchestra BioMed into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between 23Andme Holding Co and Orchestra BioMed Holdings, you can compare the effects of market volatilities on 23Andme Holding and Orchestra BioMed and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in 23Andme Holding with a short position of Orchestra BioMed. Check out your portfolio center. Please also check ongoing floating volatility patterns of 23Andme Holding and Orchestra BioMed.

Diversification Opportunities for 23Andme Holding and Orchestra BioMed

-0.39
  Correlation Coefficient

Very good diversification

The 3 months correlation between 23Andme and Orchestra is -0.39. Overlapping area represents the amount of risk that can be diversified away by holding 23Andme Holding Co and Orchestra BioMed Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Orchestra BioMed Holdings and 23Andme Holding is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on 23Andme Holding Co are associated (or correlated) with Orchestra BioMed. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Orchestra BioMed Holdings has no effect on the direction of 23Andme Holding i.e., 23Andme Holding and Orchestra BioMed go up and down completely randomly.

Pair Corralation between 23Andme Holding and Orchestra BioMed

Allowing for the 90-day total investment horizon 23Andme Holding Co is expected to under-perform the Orchestra BioMed. In addition to that, 23Andme Holding is 1.03 times more volatile than Orchestra BioMed Holdings. It trades about -0.1 of its total potential returns per unit of risk. Orchestra BioMed Holdings is currently generating about -0.02 per unit of volatility. If you would invest  790.00  in Orchestra BioMed Holdings on September 3, 2024 and sell it today you would lose (227.00) from holding Orchestra BioMed Holdings or give up 28.73% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

23Andme Holding Co  vs.  Orchestra BioMed Holdings

 Performance 
       Timeline  
23Andme Holding 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days 23Andme Holding Co has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's technical and fundamental indicators remain rather sound which may send shares a bit higher in January 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.
Orchestra BioMed Holdings 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Orchestra BioMed Holdings has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy forward indicators, Orchestra BioMed is not utilizing all of its potentials. The current stock price disarray, may contribute to short-term losses for the investors.

23Andme Holding and Orchestra BioMed Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with 23Andme Holding and Orchestra BioMed

The main advantage of trading using opposite 23Andme Holding and Orchestra BioMed positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if 23Andme Holding position performs unexpectedly, Orchestra BioMed can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Orchestra BioMed will offset losses from the drop in Orchestra BioMed's long position.
The idea behind 23Andme Holding Co and Orchestra BioMed Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.

Other Complementary Tools

Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Equity Valuation
Check real value of public entities based on technical and fundamental data
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.